Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Cameron

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Journal of Toxicology. Clinical Toxicology|January 1, 1996
Efficacy of deferiprone in the treatment of acute iron intoxication in ratsF F Fassos, M Berkovitch, N Daneman, et al.
Toxicology and Applied Pharmacology|September 15, 1990
Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1B A Quinn, T L Crane, T E Kocal, et al.
The American Journal of Physiology|January 1, 1991
Body composition and metabolic rate in rat during a continuous infusion of cachectinE Hoshino, C Pichard, C E Greenwood, et al.
Clinical Biochemistry|June 16, 2001
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicityM G Neuman, N H Shear, P M Jacobson-Brown, et al.
The New England Journal of Medicine|August 13, 1998
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia majorN F Olivieri, G M Brittenham, C E McLaren, et al.
Plant Physiology|September 1, 1986
Photosynthesis of F(1) Hybrids between C(4) and C(3)-C(4) Species of FlaveriaR H Brown, C L Bassett, R G Cameron, et al.
The New England Journal of Medicine|April 6, 1995
Iron-chelation therapy with oral deferiprone in patients with thalassemia majorN F Olivieri, G M Brittenham, D Matsui, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Mechanisms of alcoholic liver disease: cytokinesM G Neuman, D A Brenner, B Rehermann, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Journal of Toxicology. Clinical Toxicology|January 1, 1996
Efficacy of deferiprone in the treatment of acute iron intoxication in ratsF F Fassos, M Berkovitch, N Daneman, et al.
Toxicology and Applied Pharmacology|September 15, 1990
Protective activity of different hepatic cytosolic glutathione S-transferases against DNA-binding metabolites of aflatoxin B1B A Quinn, T L Crane, T E Kocal, et al.
The American Journal of Physiology|January 1, 1991
Body composition and metabolic rate in rat during a continuous infusion of cachectinE Hoshino, C Pichard, C E Greenwood, et al.
Clinical Biochemistry|June 16, 2001
CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicityM G Neuman, N H Shear, P M Jacobson-Brown, et al.
The New England Journal of Medicine|August 13, 1998
Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia majorN F Olivieri, G M Brittenham, C E McLaren, et al.
Plant Physiology|September 1, 1986
Photosynthesis of F(1) Hybrids between C(4) and C(3)-C(4) Species of FlaveriaR H Brown, C L Bassett, R G Cameron, et al.
The New England Journal of Medicine|April 6, 1995
Iron-chelation therapy with oral deferiprone in patients with thalassemia majorN F Olivieri, G M Brittenham, D Matsui, et al.
Alcoholism, Clinical and Experimental Research|June 8, 2001
Mechanisms of alcoholic liver disease: cytokinesM G Neuman, D A Brenner, B Rehermann, et al.
Pageof 7